Cary Street Partners’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.4M Buy
104,829
+1,108
+1% +$161K 0.34% 69
2026
Q1
$15M Sell
103,721
-4,543
-4% -$689K 0.37% 65
2025
Q4
$15.5M Sell
108,264
-2,966
-3% -$437K 0.38% 59
2025
Q3
$17.1M Buy
111,230
+36
+0% +$5.62K 0.44% 48
2025
Q2
$17.7M Sell
111,194
-41,559
-27% -$6.78M 0.5% 46
2025
Q1
$26M Sell
152,753
-1,079
-0.7% -$181K 0.82% 22
2024
Q4
$25.8M Buy
+153,832
New +$26.2M 0.84% 23

Other funds holding PG

Cary Street Partners's PG Position: Q2 2026 in Review

Cary Street Partners increased its Procter & Gamble (PG) stake by 1.1% in Q2 2026, buying an estimated $161K and bringing the position to 104,829 shares worth $15.4M. The position accounts for 0.34% of the portfolio, ranked #69.

Cary Street Partners first reported a position in PG in Q4 2024 and has held it in 7 quarters since. The position peaked at $26M in Q1 2025. 1,371 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Cary Street Partners held 104,829 shares of Procter & Gamble worth $15.4M as of Q2 2026.
  • Cary Street Partners bought 1,108 Procter & Gamble shares in Q2 2026, an estimated $161K.
  • Procter & Gamble made up 0.34% of Cary Street Partners's portfolio in Q2 2026, its #69 holding.
  • Cary Street Partners first reported a position in Procter & Gamble in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's Procter & Gamble position peaked at $26M in Q1 2025.
  • 1,371 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.